Assessment of endothelial dysfunction by flow-mediated dilatation in men on long-term androgen deprivation therapy for prostate cancer

Does Comorbidity Influence the Risk of Myocardial Infarction or Diabetes During Androgen-Deprivation Therapy for Prostate Cancer?

(2012) Nancy L. Keating et al.   EUROPEAN UROLOGY

Circulating Endothelial Cells as Marker of Endothelial Damage in Male Hypogonadism

(2012) D. Milardi et al.   JOURNAL OF ANDROLOGY

A new approach to improve the specificity of flow-mediated dilation for indicating endothelial function in cardiovascular research

(2012) Greg Atkinson et al.   JOURNAL OF HYPERTENSION

Endogenous Testosterone, Endothelial Dysfunction, and Cardiovascular Events in Men with Nondialysis Chronic Kidney Disease

(2011) M. I. Yilmaz et al.   Clinical Journal of the American Society of Nephrology

Changes in blood glucose and cholesterol levels due to androgen deprivation therapy in men with non-metastatic prostate cancer

(2011) Hassanabbas Z. Mohamedali et al.   CUAJ-Canadian Urological Association Journal

Androgen Deprivation Therapy and the Risk of Coronary Heart Disease and Heart Failure in Patients with Prostate Cancer

(2011) Elisa Martín-Merino et al.   DRUG SAFETY

Cardiovascular risk in androgen suppression: underappreciated, under-researched and unresolved: Figure 1

(2011) Liam Bourke et al.   HEART

Assessment of flow-mediated dilation in humans: a methodological and physiological guideline

(2010) Dick H. J. Thijssen et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular Risk: A Science Advisory From the American Heart Association, American Cancer Society, and American Urological Association: Endorsed by the American Society for Radiation Oncology

(2010) G. N. Levine et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Low serum testosterone and increased mortality in men with coronary heart disease

(2010) C. J. Malkin et al.   HEART

Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis

(2010) Yoichi Inaba et al.   INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING

Absolute and Relative Risk of Cardiovascular Disease in Men With Prostate Cancer: Results From the Population-Based PCBaSe Sweden

(2010) Mieke Van Hemelrijck et al.   JOURNAL OF CLINICAL ONCOLOGY

The effect of androgen deprivation therapy on body composition in men with prostate cancer: Systematic review and meta-analysis

(2010) Farhana Haseen et al.   Journal of Cancer Survivorship

The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process

(2009) T. Hugh Jones et al.   ATHEROSCLEROSIS

Predictive Value of Brachial Flow-Mediated Dilation for Incident Cardiovascular Events in a Population-Based Study

(2009) Joseph Yeboah et al.   CIRCULATION

Pick your Poiseuille: normalizing the shear stimulus in studies of flow-mediated dilation

(2009) Beth A. Parker et al.   JOURNAL OF APPLIED PHYSIOLOGY

Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy: Observational Study of Veterans With Prostate Cancer

(2009) N. L. Keating et al.   JNCI-Journal of the National Cancer Institute

Body composition changes during androgen deprivation therapy for prostate cancer: A 2-year prospective study

(2008) Gijsberta J. van Londen et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Early Versus Delayed Endocrine Treatment of T2-T3 pN1-3 M0 Prostate Cancer Without Local Treatment of the Primary Tumour: Final Results of European Organisation for the Research and Treatment of Cancer Protocol 30846 After 13 Years of Follow-up (A Randomised Controlled Trial)

(2008) Fritz H. Schröder et al.   EUROPEAN UROLOGY

Importance of Measuring the Time Course of Flow-Mediated Dilatation in Humans

(2007) Mark A. Black et al.   HYPERTENSION